GOSS
Gossamer Bio Inc
NASDAQ: GOSS · HEALTHCARE · BIOTECHNOLOGY
$0.37
+5.21% today
Updated 2026-04-30
Market cap
$81.79M
P/E ratio
—
P/S ratio
1.69x
EPS (TTM)
$-0.75
Dividend yield
—
52W range
$0 – $4
Volume
18.7M
Gossamer Bio Inc (GOSS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-333.70%
ROE
-783.00%
ROA
-41.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $0.00 | $-83000.00 | — | — | — |
| 2017 | $0.00 | $-6.77M | — | — | — |
| 2018 | $0.00 | $-146.97M | — | — | — |
| 2019 | $0.00 | $-180.82M | — | — | — |
| 2020 | $0.00 | $-243.36M | — | — | — |
| 2021 | $0.00 | $-234.00M | — | — | — |
| 2022 | $0.00 | $-229.38M | — | — | — |
| 2023 | $0.00 | $-179.82M | — | — | — |
| 2024 | $114.70M | $-56.53M | 100.00% | -52.24% | -49.28% |
| 2025 | $48.47M | $-170.37M | 97.93% | -336.81% | -351.49% |